The Woo lab uses cardiac surgery and coronary ligation as a model to study ischemic cardiomyopathy and stem cell biology, as well as to test novel molecular and cellular therapeutics. In vivo models include small animal (rodents), large animal (sheep and pigs), as well as human clinical trials. The lab principally focuses on developing therapies that prevent ischemic cardiomyopathy through angiogenesis, myocardial regeneration, or development of engineered symbiotic relationships.